Company profile: Avid Bioservices
1.1 - Company Overview
Company description
- Provider of end-to-end biologics services, including mammalian protein process development, drug substance development, CGMP manufacturing from early stages to commercial scale, and analytical services; also specializes in viral vector design, optimization, and scalable production for gene therapy and vaccine applications. Expansion doubles capacity to service a $40m backlog and support owner Peregrine.
Products and services
- Mammalian Protein CGMP Manufacturing: Builds CGMP-compliant mammalian protein manufacturing, spanning early-stage development to large-scale commercialization, supported by expansion doubling capacity to service a $40m backlog and Peregrine programs
- Mammalian Protein Development & Manufacturing Services: Delivers industrial-grade, end-to-end biologics development for mammalian proteins, from early-stage activities through commercial-scale production, aligning development and manufacturing under one coordinated offering
- Viral Vector Development & Manufacturing Services: Architects, optimizes, and fabricates scalable viral vectors for gene therapy and vaccine applications, with integrated design, optimization, and production workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avid Bioservices
Frenova
HQ: United States
Website
- Description: Provider of contract clinical research and site management for renal and adjacent conditions. Services include renal consulting, project management, bioinformatics and analytics; a global network of research-ready sites with tech-enabled patient screening and enrollment; data analytics/licensing with a 25-year longitudinal nephrology database; a genomics research program and the F1RST UP network to speed trial start-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frenova company profile →
Tentamus Group
HQ: Germany
Website
- Description: Provider of product safety and quality testing through a network of specialized laboratories. Services include analysis of food, water (particularly drinking water), feed, dietary supplements, pharmaceuticals, and agrosciences (fertilizers and crop protection). Capabilities span chemical, instrumental, physico-chemical, microbiological, molecular biological, and mechanical testing to ensure marketability and safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tentamus Group company profile →
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
Clinvest Research
HQ: United States
Website
- Description: Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinvest Research company profile →
ZenBio
HQ: United States
Website
- Description: Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZenBio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avid Bioservices
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avid Bioservices
2.2 - Growth funds investing in similar companies to Avid Bioservices
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avid Bioservices
4.2 - Public trading comparable groups for Avid Bioservices
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →